Pressmeddelande

BioStock: CLS revises strategy – increases focus on neurosurgery

Cision Publicerad: 24 May 09:21

Clinical Laserthermia Systems revises its strategy to increase the possibility of achieving the goal of reaching a positive cash flow in 2026. The new strategy prioritizes the neurosurgery business area, enabling cost savings of approximately SEK 65 million.
– The background to the announced changes to the business is the strength of the ClearPoint Prism product offering, a strength that has become increasingly clear in the spring of 2024 through the initial market launch in the US, CLS writes.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/05/cls-revises-strategy-increases-focus-on-neurosurgery/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Nyheter om Clinical Laserthermia

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!